# 68Ga-DOTATATE Neuroblastoma Imaging Pilot

> **NCT04559217** · PHASE2 · RECRUITING · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 20 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** Radiopharmaceutical 68Ga-DOTATATE

## Key facts

- **NCT ID:** NCT04559217
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-06
- **Primary completion:** 2026-12-15
- **Final completion:** 2027-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559217, "68Ga-DOTATATE Neuroblastoma Imaging Pilot". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04559217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*